The detection of genital tract infection by Papanicolaou-stained tests

Cytopathology

Volumn 17, Issue 6, 2006, Pages 317-322

  McMillan, A ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Cervical screening; Cytodiagnosis; Cytological techniques; Diagnosis; Laboratory diagnosis; Papanicolaou stained cervical smears; Sexually transmitted infections

Indexed keywords

ARTICLE; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FEMALE; GENITAL TRACT INFECTION; HUMAN; LABORATORY DIAGNOSIS; MICROSCOPY; PAPANICOLAOU TEST; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; STAINING; UTERINE CERVIX CYTOLOGY;

ANIMALS; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; VAGINAL SMEARS;

EID: 33751308372     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2006.00411.x     Document Type: Article

References (26)

1. Wilbur DC, Prey MU, Miller WM, Pawlick GF, Colgan TJ, Taylor DD. AutoPap system detection of infections and benign cellular changes: results from primary screener clinical trials. Diagn Cytopathol 1999;21:355-8.
2. Mason PR, Super H, Fripp PJ. Comparison of four techniques for the routine diagnosis of Trichomonas vaginalis infection. J Clin Pathol 1976;29:154-7.
3. Krieger JN, Tam MR, Stevens CE, et al. Diagnosis of trichomoniasis. Comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens. JAMA 1988;259:1223-7.
4. Wiese W, Patel SR, Patel S, Ohl CA, Estrada CA. A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis. Am J Med 2000;108:301-8.
5. Larra-Torre E, Pinkerton JS. Accuracy of detection of Trichomonas vaginalis organisms on a liquid-based Papanicolaou smear. Am J Obstet Gynecol 2003;188:354-6.
6. Aslan DL, McKeon DM, Stelow EB, Gulbahce HE, Kjedahl K, Pambuccian SE. The diagnosis of trichomoniasis in liquid-based Pap tests: morphological characteristics. Diagn Cytopathol 2005;32:253-9.
7. Audisio T, Pigini T, De Riutort SV, Schindler L, et al. Validity of the Papanicolaou smear in the diagnosis of Candida spp., Trichomonas vaginalis, and bacterial vaginosis. J Low Genit Tract Dis 2001;5:223-5.
8. Cayley J, Fotherby K, Guillebaud J, et al. Recommendations for clinical practice: actinomyces-like organisms and intrauterine contraceptives. The Clinical and Scientific Committee. Br J Fam Plann 1998;23:137-8.
9. Petitti DB, Yamamoto D, Morgenstern N. Factors associated with actinomyces-like organisms on Papanicolaou smear in users of intrauterine contraceptive devices. Am J Obstet Gynecol 1983;145:338-41.
10. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983;74:14-22.
11. Current Issues. The 1991 Bethesda System for reporting cervical/vaginal cytological diagnosis. Diagn Cytopathol 1993: 9:235-43.
12. Davis JD, Connor E, Wilinson EJ, Duff P. Correlation between cervical cytologic results and Gram stain as diagnostic tests for bacterial vaginosis. Am J Obstet Gynecol 1997;177:532-5.
13. Sekhri A, Le Faou AE, Tardieu JC, Antz M, Fabre M. What can be expected from the cytologic examination of cervicovaginal smears for the diagnosis of Chlamydia trachomatis infections? Acta Cytol 1988: 32:805-10.
14. Forster GE, Cookey I, Munday PE, et al. Investigation into the value of Papanicolaou stained smears for the diagnosis of chlamydial cervical infection. J Clin Pathol 1985;38:399-402.
15. Koumans EH, Black CM, Markowitz LE, et al. Comparison of methods for detection of Chlamydia trachomatis and Neisseria gonorrhoeae using commercially available nucleic acid amplification tests and liquid pap medium. J Clin Microbiol 2003: 41:1507-11.
16. Heller CJ. Neisseria gonorrhoeae in Papanicolaou smears. Acta Cytol 1974;18:338-40.
17. Genevert GI, Drusin LM, Seybolt JF, Braun DW. Evaluation of the Papanicolaou-stained cytological smear as a screening technique for asymptomatic gonorrhoea. Br J Vener Dis 1980;56:400-3.
18. Ng ABP, Reagan JW, Lindner E. The cellular manifestations of primary and recurrent herpes genitalis. Acta Cytol 1970;14:124-9.
19. Brown ST, Jaffe HW, Zaida A, et al. Sensitivity and specificity of diagnostic tests for genital infection with Herpesvirus hominis. Sex Transm Dis 1979;6:10-3.
20. Koutsky LA, Kiviat NB. Genital human papillomavirus. In: Sexually Transmitted Diseases. Holmes KK, Sparling PF, Mardh P-A, Lemon SM, Stamm WE, Piot P, Wasserheit JN (eds). New York: McGraw-Hill; 1999: pp. 347-59.
21. Syrjanen K, Syrjanen S. Epidemiology of human papillomavirus infections and genital neoplasia. Scand J Infect Dis 1990;69(Suppl.): 7-17.
22. Melkert PW, Hopman E, van den Brule AJ, et al. Prevalence of HPV in cytomorphologicaly normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer 1993;53:919-23.
23. Evander M, Edlund K, Gustaffson A, et al. Human papillomavirus infection is transient in young women: a population-based cohort. J Infect Dis 1995;171:1026-30.
24. Ho GYF, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8.
25. Maissi E, Marteau TM, Hankins M, Moss S, Legood R, Gray A. Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear results: cross sectional questionnaire study. BMJ 2004;328:1293-8.
26. Ferenczy A, Franco EL. Human papillomavirus DNA testing using liquid based cytology. In: New Developments in Cervical Cancer Screening and Prevention. Franco EL, Monsonego J (eds). Oxford: Blackwell Science; 1997: pp. 348-53.